JP2010536740A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536740A5
JP2010536740A5 JP2010520669A JP2010520669A JP2010536740A5 JP 2010536740 A5 JP2010536740 A5 JP 2010536740A5 JP 2010520669 A JP2010520669 A JP 2010520669A JP 2010520669 A JP2010520669 A JP 2010520669A JP 2010536740 A5 JP2010536740 A5 JP 2010536740A5
Authority
JP
Japan
Prior art keywords
methyl
thiazole
amino
carbonyl
amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2010520669A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536740A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/053264 external-priority patent/WO2009022311A2/en
Publication of JP2010536740A publication Critical patent/JP2010536740A/ja
Publication of JP2010536740A5 publication Critical patent/JP2010536740A5/ja
Ceased legal-status Critical Current

Links

JP2010520669A 2007-08-15 2008-08-14 1,2−ジアミド−エチレン誘導体 Ceased JP2010536740A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2007053249 2007-08-15
PCT/IB2008/053264 WO2009022311A2 (en) 2007-08-15 2008-08-14 1,2-diamido-ethylene derivatives as orexin antagonists

Publications (2)

Publication Number Publication Date
JP2010536740A JP2010536740A (ja) 2010-12-02
JP2010536740A5 true JP2010536740A5 (en:Method) 2011-09-15

Family

ID=40206260

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010520669A Ceased JP2010536740A (ja) 2007-08-15 2008-08-14 1,2−ジアミド−エチレン誘導体

Country Status (12)

Country Link
US (1) US20110263662A1 (en:Method)
EP (1) EP2188282B1 (en:Method)
JP (1) JP2010536740A (en:Method)
KR (1) KR20100055464A (en:Method)
CN (1) CN101778846B (en:Method)
AU (1) AU2008288151A1 (en:Method)
BR (1) BRPI0815079A2 (en:Method)
CA (1) CA2694993A1 (en:Method)
ES (1) ES2400830T3 (en:Method)
MX (1) MX2010001575A (en:Method)
RU (1) RU2010109455A (en:Method)
WO (1) WO2009022311A2 (en:Method)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8084601B2 (en) 2008-09-11 2011-12-27 Royal Holloway And Bedford New College Royal Holloway, University Of London Oligomers
WO2010044054A1 (en) * 2008-10-14 2010-04-22 Actelion Pharmaceuticals Ltd Phenethylamide derivatives and their heterocyclic analogues
EP2491031B1 (en) 2009-10-23 2013-08-07 Janssen Pharmaceutica N.V. Fused heterocyclic compounds as orexin receptor modulators
US8680275B2 (en) 2009-10-23 2014-03-25 Janssen Pharmaceutica Nv Fused heterocyclic compounds as orexin receptor modulators
ME02437B (me) 2009-10-23 2016-09-20 Janssen Pharmaceutica Nv Disupstituirani oktahidropirolo[3,4-c]piroli kao modulatori oreksin receptora
WO2011073316A1 (en) * 2009-12-18 2011-06-23 Novartis Ag 4-aryl-butane-1,3-diamides
JP5847830B2 (ja) * 2010-11-10 2016-01-27 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd オレキシン受容体拮抗薬として有用なラクタム誘導体
US9586962B2 (en) 2011-04-20 2017-03-07 Janssen Pharmaceutica Nv Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
US9440982B2 (en) 2012-02-07 2016-09-13 Eolas Therapeutics, Inc. Substituted prolines/piperidines as orexin receptor antagonists
BR112014019426A8 (pt) 2012-02-07 2017-07-11 Eolas Therapeutics Inc Prolinas/ piperidinas substituídas como antagonistas do receptor de orexina
AR098436A1 (es) * 2013-11-19 2016-05-26 Actelion Pharmaceuticals Ltd Compuestos tricíclicos de piperidina
AR101558A1 (es) 2014-08-13 2016-12-28 Eolas Therapeutics Inc Difluoropirrolidinas como moduladores del receptor de orexina
GB201415569D0 (en) * 2014-09-03 2014-10-15 C4X Discovery Ltd Therapeutic Compounds
GB201601703D0 (en) 2016-01-29 2016-03-16 C4X Discovery Ltd Therapeutic compounds
AU2017217931B2 (en) 2016-02-12 2020-10-22 Astrazeneca Ab Halo-substituted piperidines as orexin receptor modulators
IL288321B2 (en) 2016-03-10 2025-08-01 Janssen Pharmaceutica Nv Methods of treating depression using orexin-2 receptor antagonists
EP3454857A1 (en) 2016-05-10 2019-03-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases
GB201702174D0 (en) 2017-02-09 2017-03-29 Benevolentai Bio Ltd Orexin receptor antagonists
GB201707504D0 (en) 2017-05-10 2017-06-21 Benevolentai Bio Ltd Orexin receptor antagonists
GB201707499D0 (en) 2017-05-10 2017-06-21 Benevolentai Bio Ltd Orexin receptor antagonists
WO2025224168A1 (en) 2024-04-24 2025-10-30 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2381995A (en) 1994-04-29 1995-11-29 Pharmacia & Upjohn Company Methanol derivatives for treatment of retroviral infections especially hiv infections
ATE293101T1 (de) * 2000-06-16 2005-04-15 Smithkline Beecham Plc Piperidine zur verwendung als orexin rezeptor antagonisten
JP4028711B2 (ja) * 2001-10-31 2007-12-26 株式会社アーレスティ 金型冷却装置
GB0130341D0 (en) 2001-12-19 2002-02-06 Smithkline Beecham Plc Compounds

Similar Documents

Publication Publication Date Title
JP2010536740A5 (en:Method)
JP2010534646A5 (en:Method)
JP2010534647A5 (en:Method)
RU2010109455A (ru) Производные 1,2-диамидоэтилена в качестве антагонистов орексина
RU2460732C2 (ru) Производные 2-аза-бицикло[3.1.0.]гексана в качестве антагонистов рецептора орексина
RU2010138640A (ru) Производные 2-аза-бицикло [2.2.1] гептана
US7897572B1 (en) Theraputic methods for type I diabetes
ES2350460T3 (es) Derivados de 3-aza-biciclo[3.1.0]hexano.
DE69916881T2 (de) Antihypertriglyceridemische, antihyperglykemische, antiangiogene und wundheilende substituierte indolalkansäure
RS59600B1 (sr) Stabilizovane kompozicije neproteinskog toksina klostridije
JP2010535816A5 (en:Method)
JP2020512337A5 (en:Method)
JP2010514751A5 (en:Method)
JP2007520440A5 (en:Method)
TW201002703A (en) Quinazolinedione derivatives as TRPA1 modulators
KR20100041805A (ko) 3-아자-비시클로[3.3.0]옥탄 화합물
RU2010106854A (ru) Производные 2-аза-бицикло[3.3.0]октана
JP2009515887A5 (en:Method)
RU2007128624A (ru) Производные пиразол-пиримидина в качестве антагонистов mglur2
JP2018509474A (ja) インダン酢酸誘導体を用いる肝疾患の治療方法
CN102333766A (zh) 甲酰胺化合物和它们作为需钙蛋白酶抑制剂的用途
JP2010523727A5 (en:Method)
JP2005521705A5 (en:Method)
US8748422B2 (en) Pharmaceutical compositions containing quinazoline derivatives for treating as serotonin receptor antagonist
CN107629022B (zh) 一种抗菌增效剂及其制法和用途